This report is about the fast-growing worldwide market for next-generation sequencing (NGS) tools and services. NGS systems makers are effectively driving down the cost of sequencing a human genome. Once the cost of full genome sequencing drops to $1,000 or less, scientists will be able sequence human genomes at the massive scale needed to better understand human variation and help open the gateway to personalized medicine. New NGS markets in medical, agriculture, bio-fuels, forensics, or others will emerge.
This must-have report discusses its interesting topics with key findings. Within a short time, the commercial NGS systems have seen a rapid uptake as these systems have been deployed into large genome centers, non-profit institutes, cancer research centers, drug makers, diagnostics firms and service providers worldwide. The report estimates that the total NGS tools and service market will reach $1.3 billion in 2011 and grow at a high double digit growth rate over the next 5-years. The report shows that various NGS systems are available to fill nearly every customer need, from high production volumes, to small scale, or to special niches.
The study reviews the technologies that these new NGS machines use and what kinds of applications and research projects that the scientists are doing. The report discusses government research grants and private initiatives. The report studies NGS service providers that outsource to pharma and biotech companies or other customers because the technologies might help them become more productive faster. Service providers such as Complete Genomics, GATC, PerkinElmer and others are convenient resources.
Takeda Pacific offers this report in an interactive PDF format. The interactive feature uses hyperlinks that enable the reader to click the mouse to jump from Table of Contents items to sections inside the report. The hyperlinks also allow the reader to click on links to Internet information.
This report is for business executives, entrepreneurs, venture capitalists, investors, product managers, research managers, business development managers, government officials and other decision makers. The research study discusses NGS products and services from Illumina, Life Technologies, Roche 454, Helicos Biosciences, Ion Torrent, Pacific Biosciences, Oxford Nanopore Technologies, and others.
The report uses 61 figures and tables to illustrate the findings. The study features convenient tables that help the reader scan the details of key trends, market segmentation, forecasts, M&As, alliances, grant funding, patents and so forth. The study profiles the activities of 19 companies.
Analysts at Takeda Pacific developed this report. The company provides business consulting that focuses on facilitating business development and market research projects. The business projects may involve European, Japanese and North American Life Science companies. Since it' s founding in late 1992, TP has reviewed or analyzed thousands of life Science and technology firms for its clients. Takeda Pacific has produced numerous industry reports about emerging pharma, biotech, medical devices and technology companies and markets.Takeda Pacific also offers follow-up consulting or custom research consulting to assist in your business development or benchmarking, market assessment projects.